Evidence map›Paper›PMID 40632026›Full record

ArticleExpert opinion on therapeutic targets2025

The trap becomes the target: molecular basis for targeted inhibition of neutrophil extracellular traps in the pre-metastatic niche.

Hironari Akasaka, WonJae Lee, Honami Naora

Abstract readEditorial
In one paragraph

Article in Expert opinion on therapeutic targets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hironari AkasakaDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
WonJae LeeDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Honami NaoraDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

Pre-metastatic Omental Niche Formation in Ovarian CancerR01CA217931 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NAORA, HONAMI · 2018 to 2022
$1.8M
Boosting anti-tumor immunity in the omentum for metastasis preventionR21CA273656 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI NAORA, HONAMI · 2023 to 2024
$405k
NCI NIH HHS R01 CA217931NCI NIH HHS R21 CA273656
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

metastasisNeutrophil extracellular trapspre-metastatic nichetargeted therapiestumor microenvironment

Identifiers

PMID40632026
PMCPMC12306876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.